EUVIMEDEUVIMED entdecken
Open Access

Targeted degradation of Pin1 by an antagonistic peptide enhances gemcitabine therapy in pancreatic cancer

Mengting Chen, Xiangyu Chu, Haipeng Zhao, Lilusi Ma, Jie Meng, Yanlian Yang, Qiaojun Fang iD, Xiaocui Fang iD, Chen Wang iD

RSC Medicinal Chemistry · 2026 · 17 (3) · 1537-1549

DOI: 10.1039/d5md00970g ↗

Kurz gefasst

Fachartikel in der Zeitschrift RSC Medicinal Chemistry, 2026. Verfasst von Mengting Chen und 8 weiteren Autor:innen. Beteiligte Einrichtung: CAS Key Laboratory of Standardization and Measurement for Nanotechnology, CAS Key Laboratory for Biomedical Effects of Nanomaterials and Nanosafety, …. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 39 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: National Key Research and Development Program of China, Natural Science Foundation of Beijing Municipality, National Natural Science Foundation of China.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

PIPWF peptide binds to the Pin1 protein through multi-site interactions, thereby inducing its conformational change and leading to subsequent degradation.

Autor:innen und Institutionen

  • CAS Key Laboratory of Standardization and Measurement for Nanotechnology, CAS Key Laboratory for Biomedical Effects of Nanomaterials and Nanosafety, National Center for Nanoscience and Technology Beijing 100190 China fa…
  • University of Chinese Academy of Sciences Beijing 100049 China.
  • Department of General Surgery, Beijing Friendship Hospital, Capital Medical University, State Key Lab of Digestive Health, National Clinical Research Center for Digestive Diseases Beijing 100050 China.

ORCID-Profile: Qiaojun Fang, Xiaocui Fang, Chen Wang

Förderung

  • National Key Research and Development Program of China
  • Natural Science Foundation of Beijing Municipality
  • National Natural Science Foundation of China

Zitieren

APA

Chen, M., Chu, X., Zhao, H., Ma, L., Meng, J., Yang, Y., Fang, Q., Fang, X., & Wang, C. (2026). Targeted degradation of Pin1 by an antagonistic peptide enhances gemcitabine therapy in pancreatic cancer. RSC Medicinal Chemistry, 17(3), 1537-1549. https://doi.org/10.1039/d5md00970g

Vancouver

Chen M, Chu X, Zhao H, Ma L, Meng J, Yang Y, et al. Targeted degradation of Pin1 by an antagonistic peptide enhances gemcitabine therapy in pancreatic cancer. RSC Medicinal Chemistry. 2026;17(3):1537-1549. doi:10.1039/d5md00970g

BibTeX
@article{Chen2026,
  author = {Chen, Mengting and Chu, Xiangyu and Zhao, Haipeng and Ma, Lilusi and Meng, Jie and Yang, Yanlian and Fang, Qiaojun and Fang, Xiaocui and Wang, Chen},
  title = {Targeted degradation of Pin1 by an antagonistic peptide enhances gemcitabine therapy in pancreatic cancer},
  journal = {RSC Medicinal Chemistry},
  year = {2026},
  volume = {17},
  number = {3},
  pages = {1537--1549},
  doi = {10.1039/d5md00970g}
}
Kostenlos starten →